Coho Partners, Ltd. Bristol Myers Squibb CO Transaction History

Coho Partners, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $1,919 - $2,176	40 Added 0.4%	10,040 $544,000
Q4 2021 Jan 14, 2022	SELL	$53.63 - $62.52 $75,082 - $87,528	-1,400 Reduced 12.28%	10,000 $623,000
Q3 2020 Nov 02, 2020	SELL	$57.43 - $63.64 $12,462 - $13,809	-217 Reduced 1.87%	11,400 $687,000
Q2 2020 Jul 28, 2020	BUY	$54.82 - $64.09 $11,895 - $13,907	217 Added 1.9%	11,617 $683,000
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $39,368 - $51,352	800 Added 7.55%	11,400 $732,000
Q1 2019 Apr 26, 2019	BUY	$45.12 - $53.8 $27,072 - $32,280	600 Added 6.0%	10,600 $506,000
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $65,912 - $75,878	-1,100 Reduced 9.91%	10,000 $632,000
Q2 2017 Aug 07, 2017	BUY	N/A	11,100	11,100 $0

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Coho Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Coho Partners, Ltd. with notifications on news.